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The pluripotent state in mouse and human
Kathryn C. Davidson1, Elizabeth A. Mason2,3 and Martin F. Pera3,4,*
ABSTRACT
In the mouse, naïve pluripotent stem cells (PSCs) are thought to
represent the cell culture equivalent of the late epiblast in the pre-
implantation embryo, with which they share a unique defining set of
features. Recent studies have focused on the identification and
propagation of a similar cell state in human. Although the capture of
an exact human equivalent of the mouse naïve PSC remains an
elusive goal, comparative studies spurred on by this quest are lighting
the path to a deeper understanding of pluripotent state regulation in
early mammalian development.
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Introduction
Many of the impressive advances in our ability to manipulate
pluripotent stem cells (PSCs) in vitro, and to convert them into
differentiated progeny for use in research and therapy, have relied
heavily on our knowledge of normal embryogenesis and the
intrinsic and extrinsic factors that control cell fate during
development. For this reason, it is important to understand where
in vitro-cultured PSCs and their lineage-specified progeny fit into
the paradigm of the developing embryo in vivo.
Shortly before implantation, the inner cell mass (ICM) of the
blastocyst gives rise to the primitive endoderm, whichwill generate the
visceral and parietal yolk sacs, and the epiblast, which represents
the precursor of all tissues of the body, including the germ line. As
post-implantation development progresses, the late epiblast becomes
poised for lineage specification. The pre-implantation epiblast
represents a naïve state of pluripotency, prior to any lineage
specification, whereas the post-implantation epiblast is said to
represent a primed pluripotent state (Fig. 1; Nichols and Smith,
2009). Pioneering work by Richard Gardner showed that, although
mouse embryonic stem cells (mESCs) can be derived from the E3.5
ICM, their actual likely cell of origin was the E4.5 epiblast (Brook and
Gardner, 1997). These studies were confirmed, and the concept
extended by other groups, in particular through the work of Austin
Smith and his colleagues (Nichols and Smith, 2011). Subsequently,
Ying, Smith and their co-workers showed in a series of experiments
that, while the original culture conditions for maintenance of mESCs
[leukaemia inhibitory factor (LIF), plus serum] resulted in a
heterogeneous mixture of cells, in the presence of small molecule
inhibitors of differentiation, mESCs could be maintained in a
homogenous naïve or ‘ground’ state that equated to the pre-
implantation epiblast (Ying et al., 2008). Smith and his colleagues,
along with other groups, have produced many lines of evidence to
argue that mESCs maintained in the naïve state are very similar in
phenotype and function to the mouse pre-implantation epiblast
(Nichols and Smith, 2009).
The derivation of human ESCs (hESCs) from the pre-
implantation blastocyst, and subsequent analysis of their
phenotype and growth requirements, revealed that they differed in
significant ways from the mouse counterparts (see below). Early on,
these findings raised the important question as to which
developmental stage the hESCs might correspond to. Some years
after the derivation of hESCs, several groups showed that it was
possible to isolate PSCs from the mouse post-implantation epiblast
(Brons et al., 2007; Tesar et al., 2007). These cells, called epiblast
stem cells or EpiSCs, although pluripotent by the criteria of in vitro
differentiation, teratoma formation and contribution to chimeras
following culture in the post-implantation epiblast in vitro (Huang
et al., 2012), were unable to participate in formation of germline
chimeras after blastocyst injection, an assay that indicates
pluripotency in vivo. The mouse EpiSC (mEpiSC) phenotype was
more similar to that of hESCs than to that of mESCs. Many
interpreted these data to mean that hESCs were in fact equivalent to
mEpiSCs, and therefore representative of a later stage of
development than that of mESCs. It followed from this hypothesis
that it ought to be possible to isolate hESCs that correspond directly
to their naïve mESC equivalents. The alternative hypothesis, that
PSCs at equivalent stages of ontogeny in the two species might
display different phenotypes, has not been widely explored, but over
the past two years a number of attempts to derive naïve human PSCs
(hPSCs) have been reported. In this Review, we will consider recent
efforts at naïve hPSC derivation in the context of background work
in the mouse, and of what is known concerning embryonic
development in the human. For a discussion of the historical
context to these studies and the potential advantages that might
accrue from derivation of naïve hPSCs, see Pera (2014).
Naïve pluripotency in the mouse
Naïve and primed cells differ in vitro
Following the development of defined culture systems that enabled the
propagation of naïve mouse PSCs (mPSCs) in a relatively pure form,
various studies identified the key features of naïve pluripotency that
corresponded to the properties of the late pre-implantation epiblast
(Table 1; Hackett and Surani, 2014). These properties include the
ability to give rise to all somatic lineages and the germ line in chimeras
following either blastocyst injection or tetraploid complementation;
expression of a specific set of genes associated with the naïve
pluripotent state; a global state of DNA hypomethylation; two active
X-chromosomes in female cell lines; a low level of bivalent histone
marks; a capacity to generate energy through both oxidative
phosphorylation (associated with a high mitochondrial content) and
glycolysis; the ability to propagate as single cells with high cloning
efficiency; a lack of lineage priming or the co-expression of
pluripotency-associated genes and lineage-specific markers.
By contrast, EpiSCs display a different pattern of pluripotency-
associated gene expression, enhanced levels of DNA methylation,
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X-inactivation, energy generation through glycolysis, poor cloning
efficiency as single cells, lineage priming and little or no ability to
participate in chimera formation (Hackett and Surani, 2014). In
addition to the characteristic changes in expression of a specific
subset of genes that marks the transition between the naïve state and
the post-implantation epiblast-like EpiSC (Table 1), the expression
of all pluripotency-associated genes is more uniform in naïve cells
in vivo or in vitro compared with EpiSCs. Low variability of gene
expression and the absence of lineage priming suggest that in vitro,
the naïve cell might represent a stable, deep attractor state (a stable
state toward which a system will evolve). However, the naïve state
converts within hours in culture (if conditions are altered) or in the
embryo, to intermediates that show wider variability in pluripotent
gene expression as well lineage priming. Hence, the naïve attractor
state is subject to rapid and facile remodelling in vivo (Kalkan and
Smith, 2014).
Recent work has refined our understanding of the developmental
status of stem cell lines corresponding to the post-implantation
epiblast. Careful comparison between gene expression in mEpiSCs
derived at different stages of post-implantation development and the
mouse epiblast from E5.5 to E8.5 shows that mEpiSCs are most
similar to the ectoderm of the anterior primitive streak, a relatively
late stage of development (Kojima et al., 2014). By modifying the
culture conditions for mEpiSCs, Wu et al. were able to derive
mEpiSCs that were more similar to late primitive streak-stage
epiblasts (Wu et al., 2015). Both of these studies indicate that
mEpiSCs are poised at a fairly late stage of epiblast development.
The naïve state: similarities and differences in vivo and in vitro
As noted above, the molecular and cellular properties of naïve PSCs
reflect the properties of the epiblast (Fig. 1). Prior to epiblast
formation, the constituent cells of the ICM are not yet committed to
the pluripotent or primitive endoderm lineages (an extra-embryonic
tissue that is the precursor of the yolk sac). Thus, prior to epiblast
segregation, levels of the pluripotency gene Nanog in the ICM are
bimodal, with low levels of expression associated with high levels
of expression of the primitive endoderm gene Gata4. After the
epiblast forms, Nanog levels are high within the pluripotent
compartment and low or undetectable in the primitive endoderm,
and gene expression in the epiblast cells reflects a uniform
pluripotent state (Boroviak et al., 2014; Guo et al., 2010). The
absence of co-expression of lineage and pluripotency markers
represents a transient state in mouse development, because very
soon after implantation, the post-implantation epiblast begins to
express germ layer lineage-specific markers in preparation for
gastrulation.
In vitro, it has repeatedly been observed that mESCs are
heterogeneous for expression of Nanog (Chambers et al., 2007).
Although mPSCs can flux between Nanog+ and Nanog– states
in vitro, this is not reflected in the embryo in vivo, where, once
epiblast cells become specified, they no longer move backwards in
developmental time to give rise to primitive endoderm (Xenopoulos
et al., 2015). mPSCs grown under conditions that support naïve
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Fig. 1. The pluripotent lineage in themouse embryo.Up to the eight-cell stage, blastomeres are totipotent. At embryonic day (E) 3.5, the inner cell mass (ICM)
cells express both pluripotency and extra-embryonic endoderm genes. At E4.5, the epiblast and primitive endoderm lineages segregate; at this stage, the epiblast
represents the naïve state of pluripotency. The E4.5 epiblast is the cell of origin of mESC; although mESC can be derived from earlier embryonic stages, the cells
of earlier embryos mature in vitro to the epiblast stage in ESC generation. In mouse, shortly after E4.5, the embryo implants in the womb. EpiLCs, which are
derived from mouse ESCs and are said to be in a state of ‘formative’ pluripotency, are thought to be equivalent to E5.5 epiblast cells. EpiSCs, which are in a
‘primed’ pluripotent state, are most similar to late E6.5 epiblast, although they may be derived from E3.5 up to E6.5. In the human (data not shown), the blastocyst
forms on day 5 and the epiblast emerges on day 6-7, when the embryo consists of 150-300 cells. For more comparison of human and mouse peri-implantation
development see Pera and Trounson (2004). The pluripotent lineage is shown in green.
Table 1. Key characteristics of the naïve and primed pluripotent stem
cell states
Naïve state PSCs Primed state PSCs
Corresponding
in vivo tissue:
Early epiblast (pre-
implantation)
Epiblast (peri-/post-
implantation)
Colony
appearance:
Compact dome Flattened
Genes
expressed:
Oct4, Nanog, Sox2,
Klf2, Klf4, Klf5,
Zpf42, Esrrb,
Dppa3, Tfcp2l1,
Fgf4, Tbx3
Oct4, Nanog, Sox2,
Dmnt3b, Fgf5,
Pou3f1, Meis1,
Otx2, Sox11, Gdf3
Oct4 enhancer
usage:
Distal Proximal
Global DNA
methylation:
Hypomethylated Hypermethylated
Female X
chromosome
status:
Two active X One inactivated X
Clonogenicity: High Low
Gene targeting
feasibility:
Amenable to gene
targeting
Low targeting
efficiency
Chimeric
contribution in
rodents:
High Low
Level of HERVH*
expression:
High Low
Growth factor
dependence:
LIF Activin, FGF2
*HERVH is a primate-specific endogenous retrovirus.
Features are based primarily on data from the mouse (Hackett and Surani,
2014), except for HERVH expression (Wang et al., 2014).
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pluripotency show more uniform Nanog expression than those
cultured in serum containing medium supplemented with LIF.
Nevertheless, a small subset of mESCs co-expresses pluripotency
and extra-embryonic endoderm markers even when maintained in
naïve culture conditions (i.e. in the presence of LIF plus GSK3 and
ERK inhibitors) (Canham et al., 2010; Marks et al., 2012; Morgani
et al., 2013). This co-expression pattern is seen at the single-cell and
population levels. Cells with this phenotype might represent an
earlier developmental state than epiblast cells, as this gene
expression phenotype is more equivalent to ICM, and these
minority cells can give rise to extra-embryonic endoderm. It has
long been observed that mESCs are able to undergo differentiation
into primitive endoderm in vitro (Niwa, 2010), a feature that is
suggestive of an ICM identity rather than that of a pure epiblast
population, and it is in fact possible to derive extra-embryonic
endoderm stem cells directly from mouse naïve ESCs (Cho et al.,
2012). Thus, even naïve mPSC cultures might contain a subset of
cells that resembles the ICM rather than the epiblast.
Alternative pluripotent states in vitro
Two groups have described stem cells that display characteristic
corresponding to an interesting intermediate state between the pre-
implantation epiblast and the epiblast at 6.5 days (Buecker et al.,
2014; Hayashi et al., 2011). These cells have been called epiblast-
like cells (EpiLCs). EpiLCs are derived from mESCs under
conditions similar to those used for maintenance of mEpiSCs or
hESCs, but unlike these cells, they cannot be maintained in culture
beyond a few days. As they form, EpiLCs switch off genes
expressed in naïve cells and switch on a subset of genes similar to
EpiSCs. In contrast to EpiSCs, however, EpiLCs can efficiently
give rise to germline cells upon chimera formation. These EpiLCs
most likely represent a rather early post-implantation epiblast cell
(around E5.5), in contrast to EpiSCs, which resemble more closely
cells of the late gastrula or primitive streak (around E6.5). Early
post-implantation epiblast cells are poised to receive signals for
somatic and germline differentiation, and such cells are thus
downstream from naïve pluripotent pre-implantation epiblast cells.
This condition has been termed a state of ‘formative’ pluripotency,
prior to entry into the primed state (Kalkan and Smith, 2014). Thus,
the generation of EpiLCs from naïve PSCs represents a
destabilization of the naïve PSC attractor state by exposure to
different growth regulatory milieu.
In summary, although it is clear that mPSCs maintained under
conditions that support the naïve state are distinct from later stages
of formative and primed pluripotency, minority populations within
these naïve cultures might represent an earlier stage of embryonic
development resembling the ICM or even the two cell stage
(Macfarlan et al., 2012).
Pluripotent states in the human embryo
Attempts to isolate naïve hPSCs with properties similar to mouse
cells are predicated on the assumption that the phenotypes of
pluripotent cells in pre- and post-implantation embryonic
development in the two species are similar. This is an assumption
difficult to validate at present. Data on post-implantation embryonic
development in primates are almost entirely confined to high quality
morphological and descriptive studies (Enders et al., 1986; Tarara
et al., 1987); no molecular characterization of the post-implantation
primate epiblast has been reported to date. Through in vitro
fertilisation it has been possible to study human development from
the zygote through to the blastocyst stage. However, in human
embryos grown in vitro, the segregation of the epiblast from
primitive endoderm is not really complete until day 6-7 of
cultivation (Kuijk et al., 2012; Roode et al., 2012), and then only
in high-quality (often hatched) blastocysts. As studies of human
embryos in vitro do not often reach this milestone, and because the
properties of the three constituent cell types of the 6-7 day embryo
are most meaningfully analysed at the single-cell level (which has
not yet been carried out in sufficient detail), the properties of the
pre-implantation human epiblast remain inadequately defined at
present.
Patterns of pluripotency-associated gene expression might differ
between human and mouse
Single-cell gene expression studies in pre-implantation embryos
provide a more detailed characterization of developmental cell
phenotypes, uncovering distinguishing patterns often masked at the
population level. Recently, Yan et al. characterised the epiblast,
trophectoderm and primitive endoderm lineages in human
blastocysts by analysis of single cells using RNAseq (Yan et al.,
2013). The RNAseq analysis was also extended to hESCs. We have
re-evaluated these data, investigating sample clustering according to
a subset of genes associated with mouse naïve and/or primed
pluripotent states (Fig. 2). The expression pattern of this gene set is
sufficient to identify discrete stages of pre-implantation
development and to segregate hPSCs from blastocyst cells. The
expression patterns of some genes characteristic of the naïve mouse
phenotype do distinguish human blastocyst cells from hPSCs, as
predicted if hPSCs are indeed equivalent to primed EpiSCs. These
genes include TFCPL1, ESSRB, TBX3 and DPPA3 (all expressed
at higher levels in blastocyst cells relative to conventional hESCs, as
predicted from the mouse), and OTX2, SOX11, GDF3, NODAL,
FST and FGFR1 (all expressed at higher levels in hESCs relative to
blastocyst, again as predicted from mouse data). However, many
genes did not fit the predicted patterns of naïve and primed states
based on data from the mouse. Indeed, we identified patterns of gene
expression that challenge the assumption that human and mouse
share equivalent developmental states. ZFP42, TEAD4, FBOX15,
NROB1, TEAD4 and KLF4 are expressed at similar levels in human
blastocyst cells and hESCs, while they are considered characteristic
markers for naïve cells in the mouse, and are downregulated in the
post-implantation epiblast and mouse EpiSCs. FGF5, POU3F1 and
MEIS1, which switch on when mouse cells exit the naïve state, are
expressed at similar levels in human blastocyst cells and hESCs.
SOX2 and NANOG are expressed at higher levels in the
conventional hESC population, as is FOXD3, whereas these
genes are more strongly expressed in naïve versus primed mouse
cells. If the blastocyst cells surveyed in this study represent the pre-
implantation epiblast stage, the comparison of gene expression
between conventional hESCs and human epiblast does not yield the
same demarcation between primed and naïve states observed in the
mouse.
There are two important caveats about the study conducted by
Yan et al. The first is that the results are based on three blastocysts
from a single study, and although they are consistent, further
assessment is clearly indicated, particularly as a subset of blastocyst
cells in this study maps close to hESCs in the principal component
analysis. The second caveat is that, in all cells of the blastocysts
studied, NANOG, GATA6 and KRT19 were expressed at high levels.
This co-expression of pluripotent and extra-embryonic marker
genes raises the possibility that the embryos had not yet actually
reached the epiblast stage of development, and that the cells studied
equate to the ICM stage in the mouse. If this is the case, comparison
of blastocyst gene expression with ESCs in this study is not
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definitive in regards to the human epiblast. Additional studies of
gene expression at the single-cell level in advanced human
blastocysts should confirm the segregation of the epiblast and
primitive endoderm lineages pre-implantation (Kuijk et al., 2012;
Roode et al., 2012), and should, in turn, provide definitive
information on gene expression in the human epiblast. Studies of
non-human primates will be required to define the key changes in
gene expression between the naïve and primed states in vivo.
Epigenetic features define naïve and primed pluripotent states
Studies of global DNA methylation in the human embryo (Guo
et al., 2014; Smith et al., 2014) have found widespread
demethylation between fertilisation and the two-cell stage, with
demethylation continuing through to the ICM stage. Demethylation
is largely complete by cleavage stages, and ESCs exhibit much
higher levels of DNA methylation compared with that of the ICM.
Indeed, DNA methylation occurs rapidly during the early phases of
ESC derivation from ICM outgrowths in vitro. As expected, the
genome of 6- to 10-week embryos has considerably higher levels of
methylation.
Another key epigenetic hallmark of the mouse naïve state is the
presence of two active X chromosomes in female cell lines. The
process of X-inactivation varies between human and mouse
(Okamoto et al., 2011; van den Berg et al., 2009). X-inactivation
is not coupled to the expression of the X inactive specific transcript
(XIST) in the human, as it is in the mouse, and much more of the
−10 −5 10 15
−5
5
MDS (Metric) naive and primed gene set
Component 1 
0
−5
5
C
om
po
ne
nt
 2
 
0
−10
B C
50−10 −5 10 1550
Key
A
–5
0
5
10
15
C
om
po
ne
nt
 3
 
DPPA3
KRT18
GATA3
AP1
TEAD4
GATA6
KLF5
TX2
FST
NODAL
CER1
FOXD3
SOX11
FGFR
GBX2
FBXO15
GATA4
EOMES
DLL1
MEIS1
POU3F1
SOX17
HOXA2
SOX6
NR0B1
WNT8A
UTF1
FGF5
FGFR2
CLDN3
FGFR4
ESRRB
TFCP2L1
TBX3
TDGF1
IFITM1
IFITM2
KRT19
TCF7L
DNMT3B
KLF114
ZFP42
GDF3
POU5F1
SOX2
ANOG
La
te
_b
la
sto
cy
st
_2
_c
el
l_
1
La
te
_b
la
sto
cy
st
_2
_c
el
l_
3
La
te
_b
la
sto
cy
st
_3
_c
el
l_
1
La
te
_b
la
sto
cy
st
_3
_c
el
l_
4
La
te
_b
la
sto
cy
st
_3
_c
el
l_
5
La
te
_b
la
sto
cy
st
_2
_c
el
l_
2
hE
SC
_P
0_
ce
ll_
1
hE
SC
_P
0_
ce
ll_
7
hE
SC
_P
0_
ce
ll_
5
hE
SC
_P
0_
ce
ll_
4
hE
SC
_P
0_
ce
ll_
2
hE
SC
_P
10
_c
el
l_
4
hE
SC
_P
10
_c
el
l_
15
hE
SC
_P
10
_c
el
l_
6
hE
SC
_P
10
_c
el
l_
18
hE
SC
_P
10
_c
el
l_
21
hE
SC
_P
0_
ce
ll_
8
hE
SC
_P
0_
ce
ll_
3
hE
SC
_P
0_
ce
ll_
6
hE
SC
_P
10
_c
el
l_
11
hE
SC
_P
10
_c
el
l_
26
hE
SC
_P
10
_c
el
l_
24
hE
SC
_P
10
_c
el
l_
9
hE
SC
_P
10
_c
el
l_
5
hE
SC
_P
10
_c
el
l_
22
hE
SC
_P
10
_c
el
l_
7
hE
SC
_P
10
_c
el
l_
20
hE
SC
_P
10
_c
el
l_
23
hE
SC
_P
10
_c
el
l_
3
hE
SC
_P
10
_c
el
l_
2
hE
SC
_P
10
_c
el
l_
25
hE
SC
_P
10
_c
el
l_
10
hE
SC
_P
10
_c
el
l_
14
hE
SC
_P
10
_c
el
l_
17
hE
SC
_P
10
_c
el
l_
8
hE
SC
_P
10
_c
el
l_
1
hE
SC
_P
10
_c
el
l_
12
hE
SC
_P
10
_c
el
l_
13
hE
SC
_P
10
_c
el
l_
16
hE
SC
_P
10
_c
el
l_
19
La
te
_b
la
sto
cy
st
_2
_c
el
l_
8
La
te
_b
la
sto
cy
st
_3
_c
el
l_
2
La
te
_b
la
sto
cy
st
_3
_c
el
l_
8
La
te
_b
la
sto
cy
st
_3
_c
el
l_
6
La
te
_b
la
sto
cy
st
_3
_c
el
l_
3
La
te
_b
la
sto
cy
st
_2
_c
el
l_
5
La
te
_b
la
sto
cy
st
_3
_c
el
l_
7
La
te
_b
la
sto
cy
st
_1
_c
el
l_
5
La
te
_b
la
sto
cy
st
_1
_c
el
l_
4
La
te
_b
la
sto
cy
st
_2
_c
el
l_
6
La
te
_b
la
sto
cy
st
_2
_c
el
l_
4
La
te
_b
la
sto
cy
st
_2
_c
el
l_
10
La
te
_b
la
sto
cy
st
_2
_c
el
l_
9
La
te
_b
la
sto
cy
st
_1
_c
el
l_
3
La
te
_b
la
sto
cy
st
_1
_c
el
l_
10
La
te
_b
la
sto
cy
st
_1
_c
el
l_
9
La
te
_b
la
sto
cy
st
_1
_c
el
l_
11
La
te
_b
la
sto
cy
st
_1
_c
el
l_
7
La
te
_b
la
sto
cy
st
_2
_c
el
l_
7
La
te
_b
la
sto
cy
st
_1
_c
el
l_
1
La
te
_b
la
sto
cy
st
_1
_c
el
l_
6
La
te
_b
la
sto
cy
st
_1
_c
el
l_
12
La
te
_b
la
sto
cy
st
_1
_c
el
l_
8
La
te
_b
la
sto
cy
st
_1
_c
el
l_
2
X
8_
ce
ll_
em
br
yo
_2
_c
el
l_
5
X
8_
ce
ll_
em
br
yo
_2
_c
el
l_
6
X
8_
ce
ll_
em
br
yo
_2
_c
el
l_
8
X
8_
ce
ll_
em
br
yo
_2
_c
el
l_
7
M
or
ul
ae
_1
_c
el
l_
8
M
or
ul
ae
_1
_c
el
l_
3
X
4_
ce
ll_
em
br
yo
_2
_c
el
l_
1
X
4_
ce
ll_
em
br
yo
_1
_c
el
l_
4
X
4_
ce
ll_
em
br
yo
_2
_c
el
l_
3
X
4_
ce
ll_
em
br
yo
_2
_c
el
l_
4
X
4_
ce
ll_
em
br
yo
_3
_c
el
l_
3
X
4_
ce
ll_
em
br
yo
_3
_c
el
l_
2
X
4_
ce
ll_
em
br
yo
_3
_c
el
l_
4
X
4_
ce
ll_
em
br
yo
_2
_c
el
l_
2
X
4_
ce
ll_
em
br
yo
_3
_c
el
l_
1
X
4_
ce
ll_
em
br
yo
_1
_c
el
l_
2
X
4_
ce
ll_
em
br
yo
_1
_c
el
l_
3
X
4_
ce
ll_
em
br
yo
_1
_c
el
l_
1
O
oc
yt
e_
1
O
oc
yt
e_
2
O
oc
yt
e_
3
Zy
go
te
_1
Zy
go
te
_3
Zy
go
te
_2
X
2_
ce
ll_
em
br
yo
_3
_c
el
l_
2
X
2_
ce
ll_
em
br
yo
_3
_c
el
l_
1
X
2_
ce
ll_
em
br
yo
_1
_c
el
l_
1
X
2_
ce
ll_
em
br
yo
_1
_c
el
l_
2
X
2_
ce
ll_
em
br
yo
_2
_c
el
l_
1
X
2_
ce
ll_
em
br
yo
_2
_c
el
l_
2
M
or
ul
ae
_2
_c
el
l_
5
M
or
ul
ae
_1
_c
el
l_
5
M
or
ul
ae
_2
_c
el
l_
1
M
or
ul
ae
_2
_c
el
l_
7
M
or
ul
ae
_2
_c
el
l_
4
M
or
ul
ae
_2
_c
el
l_
6
M
or
ul
ae
_2
_c
el
l_
3
M
or
ul
ae
_1
_c
el
l_
6
M
or
ul
ae
_1
_c
el
l_
2
M
or
ul
ae
_2
_c
el
l_
2
M
or
ul
ae
_2
_c
el
l_
8
M
or
ul
ae
_1
_c
el
l_
7
M
or
ul
ae
_1
_c
el
l_
1
M
or
ul
ae
_1
_c
el
l_
4
X
8_
ce
ll_
em
br
yo
_3
_c
el
l_
3
X
8_
ce
ll_
em
br
yo
_3
_c
el
l_
8
X
8_
ce
ll_
em
br
yo
_3
_c
el
l_
2
X
8_
ce
ll_
em
br
yo
_3
_c
el
l_
5
X
8_
ce
ll_
em
br
yo
_3
_c
el
l_
1
X
8_
ce
ll_
em
br
yo
_3
_c
el
l_
4
X
8_
ce
ll_
em
br
yo
_3
_c
el
l_
7
X
8_
ce
ll_
em
br
yo
_2
_c
el
l_
1
X
8_
ce
ll_
em
br
yo
_1
_c
el
l_
4
X
8_
ce
ll_
em
br
yo
_2
_c
el
l_
4
X
8_
ce
ll_
em
br
yo
_1
_c
el
l_
3
X
8_
ce
ll_
em
br
yo
_2
_c
el
l_
2
X
8_
ce
ll_
em
br
yo
_2
_c
el
l_
3
X
8_
ce
ll_
em
br
yo
_3
_c
el
l_
6
X
8_
ce
ll_
em
br
yo
_1
_c
el
l_
1
X
8_
ce
ll_
em
br
yo
_1
_c
el
l_
2
MDS (Metric) naive and primed gene set
Oocyte
Zygote
2 cell embryo
4 cell embryo
8 cell embryo
Morulae 1
Morulae 2
Late blastocyst 1
Late blastocyst 2
Late blastocyst 3
hESC P0
hESC P10
Fig. 2. Heat map of hierarchical cluster analysis (A) and principal component analysis (B and C) of single-cell gene expression analysis of human
embryonic cells and human embryonic stem cells (ESCs). Data are from Yan et al. (2013) and were re-analysed using the gene set listed in A, which
comprises a range of geneswith particular relevance for the transition between naïve and primed pluripotency based onmouse data. In A, colour scale bar depicts
log2 RKPM values. Consistent with the original publication, all RefSeq genes expressed in at least one of the samples with RPKM≥0.1 were used for the analysis.
B and C show multidimensional scaling plots representing the first, second and third principal components that drive clustering of samples from all stages of
preimplantation development and human ESCs. Principal components were calculated based on the expression of all genes in the naïve and primed gene sets
listed in A. C, same colour legend as A and B.
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human X chromosome escapes X-inactivation. In the human, a long
non-coding RNA called X active specific transcript (XACT, which
does not exist in the mouse) coats the active X chromosome and
might be responsible for protecting the active X from inactivation
(Vallot et al., 2013). The timing and degree of synchrony of X-
inactivation during human development have not been not clearly
elucidated, but the available data indicate that there are two active X
chromosomes in most cells of the ICM which must undergo
inactivation shortly after this stage of development.
Signalling pathways involved in early lineage specification differ
between mouse and human
The extrinsic signalling pathways governing early lineage
specification are not equivalent between mouse and human
embryos. For example, FGF signalling activation in pre-
implantation development has opposing effects in the ICM of the
two species. FGF signalling in the mouse ICM is required for
differentiation of some of its constituent cells into primitive
endoderm. However, blockade of FGF signalling has no effect on
the segregation of the primitive endoderm lineage from the epiblast
in human embryos (Kuijk et al., 2012; Roode et al., 2012). The role
of FGF signalling is important because this pathway is also required
for the self-renewal of conventional hESCs and, indeed, most naïve
populations of hESCs in vitro (see below).
In summary, the embryological roadmap for understanding the
true identity of hPSCs in the context of pre- and post-implantation
development in human is still fragmentary, but it is improving
steadily. It is already apparent that, whereas many features of the
development of the pluripotent cells in the embryo are conserved
between mouse and human, there are some important and
significant differences.
Towards human naïve PSCs?
Human or non-human primate PSCs with some features of naïve
pluripotency have been derived by the conversion of conventional
hESCs or induced PSCs (iPSCs) in vitro, through reprogramming of
somatic cells to a pluripotent state or by direct derivation from the
embryo (Tables 2 and 3) (Buecker et al., 2010; Chan et al., 2013;
Fang et al., 2014; Gafni et al., 2013; Hanna et al., 2010; Li et al.,
2009; Takashima et al., 2014; Theunissen et al., 2014; Valamehr
et al., 2014; Ware et al., 2014, Wang et al., 2014). Early studies used
exogenous transgenes to trigger the conversion from primed to
naïve pluripotency and, in some cases, to stabilise and maintain the
naïve state. Dependence on continued transgene expression is not a
desirable feature for many applications of hPSCs; thus, subsequent
studies focused on conditions that could maintain cells in the naïve
state without the need for expression of exogenous transgenes.
Several protocols have been established for the maintenance of
naïve hPSCs in vitro in the absence of transgene expression, but
each produces a different transcriptional profile depending on the
signalling pathways targeted. Below, we describe the methods used
to generate human naïve cells and the results of the characterization
of the cells phenotype in vitro and their developmental potential in
vivo.
Modifying culture protocols to generate human naïve cells
The culture systems devised to support naïve pluripotent human
cells vary considerably. Most are based around the original concept
of using inhibitors of MEK/ERK and GSK3B along with LIF in
the absence of a feeder layer, as described for naïve mESC
propagation (Ying et al., 2008). However, this system, in its
original form, has universally failed to maintain hPSCs (see
references in Tables 2 and 3). Therefore, a range of small molecule
inhibitors that support some aspects of naïve pluripotency in
human cells has been identified using various assays, mostly
comprising empirical screening approaches. Although these
systems are rather diverse, many employ FGF2 and some form
of TGF-β superfamily agonist, and most employ mouse embryonic
fibroblast feeder cell support and complex protein additives such as
knockout serum replacement (KSR) (Tables 2 and 3). These
systems are thus much less defined than the elegantly minimalist 2i
conditions described by Smith and co-workers (Ying et al., 2008).
It thus appears that if human cells analogous to naïve mESCs exist,
their growth requirements are rather different. In particular, the
activity of FGF in mouse versus human PSCs appears to represent a
fundamental difference between the species, reflected in the
activity of this factor in the embryos of the two species, as
mentioned above. The action of FGF2 in hPSC maintenance is
probably mediated through PI3K rather than the MEK/ERK
pathway (Singh et al., 2012), so inhibition of the latter pathway,
as originally described in the mouse and implemented in most
naïve hPSC protocols, will not disrupt the positive action of the
FGF2 in promoting hPSC self-renewal. It is most important to note,
in undertaking comparisons of putative naïve cells with
conventional hPSCs, that culture systems for the latter differ
from laboratory to laboratory (Tables 2 and 3).
Table 2. Protocols for transgene independent derivation or conversion of human naïve PSCs
Basal medium Growth factors/inhibitors Feeders/matrix [O2]
Conventional primed conditions
for comparison References
Albumax+N2 or
20% KSR
2iL, FGF2, TGF-β, ROCKi, JNKi,
p38i, PKCi, insulin
Gelatine/VN or
MEFs
20% 15% KSR+FGF2, TGF-β on
gelatine/VN or MEFs
Gafni et al., 2013
TeSR1* 2iL, FGF2, TGF-β, BMPi MEFs 20%‡ TeSR1, FGF2, TGF-β on matrigel Chan et al., 2013
20% KSR 2iL±FGF2 MEFs 5% 20% KSR+FGF2 on MEFs or
matrigel
Ware et al., 2014
20% KSR 2iL, FGFRi MEFs 5% 20% KSR+FGF2 on MEFs or
matrigel
Ware et al., 2014
N2B27 2iL, Activin, SRCi, ROCKi,
BRAFi±FGF2
MEFs 5% 15% FBS, 5% KSR+FGF2 on
MEFs
Theunissen et al.,
2014
KSR, knockout serum replacement; i, inhibitor; hLIF, human leukaemia inhibitory factor; 2iL, MEKi, GSK3i, hLIF; VN, vitronectin; MEFs; mouse embryonic
fibroblasts; N2B27, chemically defined medium containing N2 and B27 supplements; FBS, foetal bovine serum; FGF, fibroblast growth factor; TGF, transforming
growth factor; BMP, bone morphogenetic protein; ROCK, Rho kinase; SRC, sarcome genes; JNK, c-Jun N-terminal kinase; PKC, protein kinase C.
*TeSR1 medium contains FGF2 and TGF-β.
‡Unless specified otherwise, assume atmospheric O2 (20%).
The components of the basal media, growth factors and small molecule pathway inhibitors, feeder cells and oxygen tension are listed, and the conditions used for
growing primed cells for comparison are outlined.
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Most human naïve systems described so far support higher
cloning efficiency than that attained with conventional hPSCs
(Table 4). However, it is well known that cells can undergo
adaptation to propagation as single cells even in conventional
culture systems (Chan et al., 2008; Hasegawa et al., 2006).
Adaptation to single-cell survival is often associated with both
epigenetic and characteristic genetic changes (Amps et al., 2011;
Garitaonandia et al., 2015), including small amplifications and
deletions that might have escaped detection in the studies to date.
Thus, it is important to distinguish between enhanced cloning
efficiency originating from a transition to a naïve state from that
engendered by other concomitant epigenetic or genetic adaptations
to culture.
Assaying the pluripotent state in vitro
The studies to date have examined a number of parameters to
determine whether the culture systems they describe in fact support
the maintenance of naïve pluripotency (Table 4). As noted above,
there is a characteristic set of genes that distinguish naïve from
primed cells in the mouse. In many of these naïve culture systems,
these genes are expressed at higher levels and more consistently
compared with conventional cultures of hESCs (Table 4). However,
it is important to recognise some limitations of these comparisons.
Conventional hPSC cultures are heterogeneous, and a careful
examination of gene expression in these cultures shows that
subsets of cells grown under conventional conditions have
distinct patterns of gene expression (see below). In fact, the data
Table 3. Protocols for transgene dependent derivation or conversion of primate naïve PSCs
Transgenes expressed Basal medium Growth factors/inhibitors Feeders/matrix [O2]
Conventional primed
conditions for comparison References
OCT4, SOX2, KLF2±MYC,
LIN28*
Albumax+N2 or
20% KSR
2iL, FGF2, TGF-β, ROCKi,
JNKi, p38i, PKCi, insulin
Gelatine/VN or
MEFs
20% 15% KSR+FGF2, TGF-β
on gelatine/VN or MEFs
Gafni et al., 2013
OCT4, SOX2, KLF4* N2B27 2iL, FGF2, Activin, SRCi,
ROCKi, BRAFi
MEFs 5% 15% FBS, 5% KSR+FGF2
on MEFs
Theunissen
et al., 2014
NANOG, KLF2* N2B27 2iL, PKCi MEFs, matrigel
or laminin
5% 20% KSR+FGF2 on MEFs Takashima
et al., 2014
OCT4, SOX2, KLF4,
NANOG, c-MYC‡
20% KSR hLIF MEFs 20%§ 20% KSR+FGF2 on MEFs Buecker et al.,
2010
OCT4, SOX2, KLF4 or
OCT4, KLF4 or KLF4,
KLF2‡
N2B27 2iL MEFs 20% 15% FBS, 5% KSR+FGF2
on MEFs
Hanna et al.,
2010
OCT4, KLF4 or KLF4,
KLF2‡
N2B27 2iL, Forskolin MEFs 20% 15% FBS, 5% KSR+FGF2
on MEFs
Hanna et al.,
2010
OCT4, SOX2, KLF4* 15% KSR+N2 2iL, FGF2, JNKi, p38i MEFs 20%§ 20% KSR+FGF2 on MEFs Fang et al., 2014
OCT4, SOX2,
SV40LT±NANOG*
20% KSR (+N2,
B27 to reprogram)
2iL, FGF2, ROCKi,
(+TGF-β to reprogram)
Matrigel or VN 20% 2% KSR+FGF2 on MEFs Valamehr et al.,
2014
OCT4, SOX2, KLF4,
c-MYC, RARG, NR5A2*
20% KSR 2iL±FGFRi STO feeders 20%§ 20% KSR+FGF2 on STO
feeders
Wang et al.,
2011
*Transient expression or induction of transgenes (constitutive expression not required).
‡Constitutive expression of transgenes required to maintain the naïve state over multiple passages.
§Unless specified otherwise, assume atmospheric O2 (20%).
KSR, knockout serum replacement; i, inhibitor; hLIF, human leukaemia inhibitory factor; 2iL, MEKi, GSK3i, hLIF; VN, vitronectin; MEFs; mouse embryonic
fibroblasts; N2B27, chemically defined medium containing N2 and B27 supplements; FBS, foetal bovine serum; FGF, fibroblast growth factor; TGF, transforming
growth factor; BMP, bone morphogenetic protein; ROCK, Rho kinase; SRC, sarcome genes; JNK, c-Jun N-terminal kinase; PKC, protein kinase C.
The components of the basal media, growth factors and small molecule pathway inhibitors, feeder cells and oxygen tension are listed, and the conditions used for
growing primed cells for comparison are outlined.
Table 4. Features used to assess candidate naïve primate PSCs
A B C D E F G H I J
Compact dome colony morphology ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ no
Gene expression similar to mouse naïve ESC ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Two active X ✓ ✓ ✓ no no ✓ ✓ ✓ – ✓
Low levels of DNA methylation ✓ – ✓ – – – – – – –
Histone marks ✓ ✓ – ✓ ✓ – – – – –
Oct4 distal enhancer usage ✓ ✓ ✓ ✓ – – ✓ – – –
Improved clonogenicity ✓ ✓ ✓ – ✓ ✓ ✓ – ✓ ✓
Chimera formation ✓ – ✓ no – ✓ – – – –
Oxidative metabolism – ✓ ✓ – – – – – – –
Diploid ✓ ✓ ✓ no ✓ ✓ ✓ ✓ – ✓
Derived from blastocyst ✓ ✓ – ✓ – – – – – –
A, Gafni et al., 2013; B, Ware et al., 2014; C, Takashima et al., 2014; D, Theunissen et al., 2014; E, Chan et al., 2013; F, Fang et al., 2014; G, Hanna et al., 2010;
H, Wang et al., 2014, I, Buecker et al., 2010; J, Valamehr et al., 2014.
✓, positive finding; ‘no’, characteristic was not observed; –, test was not performed.
The various cellular and molecular features used to assess naïve cells are listed. The table is not intended to provide a rating of the various studies but rather to
indicate the range of tests performed on the cells by the various groups. Interpretation of these findings is complicated, owing to gaps in our knowledge of primate
development (e.g. gene expression, X-chromosome inactivation) and limitations of the assays themselves (e.g. clonogenicity, chimera formation), as discussed
in the text.
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on single-cell gene expression in the human embryo discussed above
would question whether expression of the mouse naïve gene set
should serve as a gold standard test to distinguish naïve and primed
pluripotent states. It is probably fair to say that an appropriate
baseline for comparison of cultured cells to the human pre-
implantation epiblast has yet to be established.
Nonetheless, much can be learned from the analysis of the results
to date. Huang et al. performed a meta-analysis in which they
compared gene expression patterns in mouse and human naïve and
primed cells, and pre-implantation embryos of both species (Huang
et al., 2014). Using a systems biology approach, these authors
analysed the gene networks in the datasets to identify co-expressed
modules and their conclusions are informative. First, as expected,
mouse naïve cells mapped to the late mouse blastocyst. Second, the
various types of human naïve cells generated with different
protocols appeared to be very different. Interestingly, the only
gene expression module conserved across several studies comprised
genes involved in RNA processing and ribosomal biogenesis, as
well as mitochondrial genes, suggesting that a common cellular
metabolic profile is a key component of these various naïve states.
Despite the variation between the studies, a general consensus was
that the human naïve cells mapped closer to the human blastocyst
stage than to the mouse blastocyst, and more nearly approximated
the late blastocyst than primed human cells did. The protocols of
Theunissen et al. (2014) and Takashima et al. (2014) yielded cells
that bore the greatest similarity to the human blastocyst.
Surprisingly, the primed cells with which the naïve cells were
being compared varied considerably between studies, even more so
than the naïve cells grown under a diverse range of conditions. This
finding suggests that variations between cell lines, culture
methodology and laboratories contribute to significant
heterogeneity in the primed (and most likely naïve) cell
phenotype. Given that a standardised methodology for the
propagation of conventional hPSCs has been in place for a decade
or so, this level of variation is surprising and should prompt a
reassessment of how we define a baseline for primed human
pluripotency. Although this meta-analysis confronts the usual
challenges of cross-platform comparisons of transcriptome data, it
does raise some important questions concerning variability between
both primed and naïve states in these studies.
As mentioned above, the epigenetic state of mouse naïve cells is
characterised by global DNA demethylation, a low level of bivalent
(activator and repressor) histone marks on chromatin and the
absence of X-inactivation in female lines. Most of the studies
reported to date describe cells that fit all of these criteria (although
the methods for the experimental definition of X-chromosome
status are variable) (Table 4). However, it is important to remember
that DNA methylation and X-inactivation status are quite variable
across conventional hPSC lines, so, again, any absolute statement
must take this heterogeneity into account. It is also worth noting
that, whereas mESCs can retain two active X-chromosomes, it has
been well known for many years that a majority of the XX mESC
lines converts to an aneuploid XO status after propagation in vitro.
Therefore, the status of X-chromosome activation in PSC lines
might be impacted by unknown factors influencing their tolerance
to a lack of dosage compensation on the X chromosome during
long-term propagation in vitro.
A key feature of the naïve state in the mouse is an enhanced
capacity for oxidative phosphorylation, along with more active
mitochondria, in contrast to EpiSCs, which rely more on glycolysis
and have less-developed mitochondria (Teslaa and Teitell, 2015).
Thus, mESCs can achieve both oxidative phosphorylation and
glycolysis. These features are important because it is now strongly
appreciated that metabolism in PSCs is tightly integrated with the
epigenetic status. Indeed, cellular pools of α-ketoglutarate (αKG, or
2-oxoglutarate) are maintained by oxidative phosphorylation in order
to keep adequate levels of this co-factor available for use by enzymes
such as TET methylcytosine dioxygenases and Jumonji domain-
containing histone demethylases, both of which require Vitamin C
and aKG as co-factors, and which maintain DNA and histones in an
hypomethylated state in mESCs (Carey et al., 2015; Blaschke et al.,
2013; Wang et al., 2011). Therefore, changes in the culture milieu,
including alterations in lowmolecular weight nutrients and co-factors
that alter metabolism or modulate key enzymatic pathways can
profoundly impact on the cellular epigenome. It remains to be
elucidated to which extent the phenotype of the naïve states described
in these studies may be driven by metabolic response to the nutrient
and physical environment, rather than by fundamental differences in
developmental status.
Assaying the pluripotent state in vivo
The developmental potential of the candidate naïve cells has been
assessed in different ways. Several studies describe the participation
of the human cells in chimera formation following transfer into
mouse blastocysts (for references, see Table 4). The extent of
chimerism observed was relatively low, and it might well be that
species differences in the pace of embryonic development preclude
extensive human cellular contribution to chimeras in these
experiments. Other studies used both teratoma formation and
in vitro differentiation as hallmarks of pluripotency. These are
certainly useful benchmarks but might lack the resolution to identify
significant differences in developmental potential. Future studies of
chimera formation in non-human primates might provide more
meaningful data on development potential of these cells. In this
regard, it is important to note that one report demonstrating the
failure of primate ESCs to contribute to conspecific embryos in a
chimeric assay revealed, unexpectedly, that ICM cells also failed to
participate in chimera formation (Tachibana et al., 2012). Only four-
cell-stage blastomeres were found to be capable of chimera
formation in this study.
A recent study using an in vitro interspecies chimera assay
reported that human naïve cells failed to incorporate into mouse
embryos (Masaki et al., 2015). By contrast, using a modification of
the naïve culture system of Gafni et al. (2013) to convert
cynomolgus monkey primed ESCs to a naïve state, Chen et al.
(2015) were able to demonstrate contributions of the resulting naïve
cells to multiple tissues representative of all three embryonic germ
layers, including germline progenitors, in two foetuses following
injection of the stem cells into host morulae and transfer back to a
foster mother. Levels of chimerism were once again low, however,
and the experiment, which required use of specific combinations of
culture media to ensure stem cell survival during embryo culture,
was not attempted with primed cells.
Modulation of the primed state of pluripotency through
manipulation of the Wnt signalling pathway can enhance the
ability of human cells to engraft mouse post-implantation embryos
in vitro (Wu et al., 2015). By contrast, naïve mESCs do not engraft
in post-implantation chimeras. In summary, chimera formation,
although a powerful assay, is one in which readout is very
dependent upon the precise state of the host cells and of the recipient
embryo, and is influenced by other factors apart from whether cells
are in a naïve or primed state.
It is known from reprogramming studies that synthetic cell states
with no analogue in normal development, such as the pluripotent F-
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class cells described by Tonge et al. (2014); see alsoWu and Izpisua
Belmonte (2014), can be isolated and maintained in vitro. Many of
the studies of naïve cells involve cultivation of cells in what might
well be highly selective media, and it is known that adaptation to
culture can involve irreversible genetic and epigenetic changes. For
these reasons, it is important to demonstrate that any culture system
purporting to support the equivalent of a normal blastocyst should
support de novo derivation of cell lines directly from the embryo,
and that the naïve cells can convert to the primed statewhen cultured
under appropriate conditions, just as embryonic cells would
progress in vivo. These conditions are not met by many of the
studies to date (Table 4).
A re-examination of hESCs
Current thinking concerning conventional hESCs considers them to
be most similar to primed state EpiSCs in the mouse. This
conclusion is based primarily on population studies that have
examined the properties of hESCs in bulk cultures. Moreover, much
of the data leading to this conclusion have been based on culture
systems that, similar to LIF plus serum inmouse, present cells with a
complex mixture of extrinsic signalling factors present in serum,
feeder cells or serum replacements, some of which drive self-
renewal and others that promote differentiation. Defined culture
systems that supply self-renewal factors in the absence of undefined
components established in the early 2000s are now coming into
wide use (Hasegawa et al., 2010; Villa-Diaz et al., 2013) and
provide a better platform for comparing human and mouse naïve
states (many of the studies comparing naïve and conventional
hESCs have not used defined culture systems for either).
In all culture systems studied to date, hPSCs exhibit a range of
biological and molecular properties that more accurately reflect a
continuous spectrum of cell states rather than a single state.
Subpopulations of cells along this continuum can be isolated on the
basis of their levels of expression of commonly used stem cell
surface markers, such as GCTM-2, CD9 and EPCAM (Hough et al.,
2009, 2014; Laslett et al., 2007). In cultures grown in serum using
feeder-cell support, isolation of cells negative for these surface
markers shows that these cells have lost the expression of some, but
not all, pluripotency-associated genes and are primed for neural
differentiation. However, in cultures grown in defined conditions
with TGF-β and FGF supplementation, very few cells are negative
for the stem cell surface markers, and very few display lineage
priming. Under such conditions, it is possible to isolate a
subpopulation with the highest levels of expression of stem cell
surface markers that expresses uniformly high levels of
pluripotency-associated genes, no lineage-specific genes and
shows high levels of self-renewal (Hough et al., 2014).
Preliminary results obtained in our lab suggest that these cells are
located towards the periphery of growing stem cell colonies in vitro
and show high levels of staining with dyes that detect mitochondrial
membrane potential (unpublished data). Previous studies have
shown that the clonogenic fraction of hESCs can be identified by
mitochondrial dye staining (Ramirez et al., 2013). These cells
located at the periphery of the stem cell colony also show high levels
of staining with SMAD3 antibodies, indicating high levels of
Activin/Nodal activity (Hough et al., 2014). The patterning of hPSC
colonies, in which cells with high levels of expression of
pluripotency markers and high levels of SMAD2/3/4 signalling
are located at the periphery, was also seen in another recent study
(Warmflash et al., 2014).
Although features such as X-inactivation and DNA methylation
have not been examined in these hPSC subpopulations yet, it appears
that the cells at the colony periphery with high self-renewal capacity
do show some features of naïve pluripotency and represent a
minority population in metastable equilibrium with other cell types.
These cells are capable of robust differentiation into derivatives
expressing genes characteristic of all three germ layers in embryoid
body assays, but in cultures maintained under defined conditions and
in the presence of TGF-β and FGF, some cells expressing high levels
of stem cell surface antigens and pluripotency-associated genes co-
express markers of extra-embryonic endoderm (Hough et al., 2014).
This suggests that, as in naïve mESC cultures, a subpopulation of
hESCs might represent an ICM-like state, capable of producing
extra-embryonic endoderm. The laboratory of Dr Brivanlou
(Warmflash et al., 2014) suggested that cells on the outer edge of
the colonies could be primed to form extra-embryonic ectoderm,
again indicative of a more primitive developmental capacity than that
of mouse epiblast.
Hence, it is possible that the interpretation that hESCs correspond
to primed mEpiSCs is misleading, and is, in part, the result of
examining the properties of bulk populations grown under
conditions that sub-optimally support maintenance of the naïve
stem cell population. These findings are reminiscent of the
comparisons of mESCs maintained in serum compared with cells
maintained in 2i. In this light, another recent study identified a small
subpopulation of hESCs (∼4%) grown under conventional culture
conditions that express the human retroviral element HERV, a
primate-specific regulator of pluripotency that is, in turn, regulated
by TFCP2L1 (a marker gene for the mouse naïve state) (Wang et al.,
2014). The minority population displayed some properties of naïve
cells including gene expression and X-inactivation. The HERV
element targets a human-specific pluripotency gene network that is
active specifically in cells expressing the retrovirus. These data,
along with previous work showing that retrotransposon integration
alters regulation of the pluripotency network in the human (Kunarso
et al., 2010), indicates that any consideration of the status of hPSCs
should make reference to these primate-specific networks on the
developmental roadmap. The existence of sub-states of pluripotency
within conventional hESC cultures shows clearly that conclusions
concerning the status of hESCs must take into account the cellular
hierarchies that exist within the cultures. This is particularly
important when comparing population data collected from
conventional hESCs grown in the presence of serum, serum
replacements or feeder cell support, with data obtained in naïve
cells. The question of heterogeneity within the naïve populations of
human cells has not yet been addressed at the single-cell level.
Conclusions
The pioneering studies of human naïve cells conducted over the past
several years and described above indicate that it is possible to
derive and maintain cultured hESC lines that display some
properties similar to that of the human blastocyst. Whether these
naïve hESCs are actually close analogues of the human epiblast
remains to be determined. We need to expand our knowledge of
early primate embryonic development if we are to answer this
question definitively, because mounting evidence suggests that
there are significant differences in the molecular and cellular
biology of pluripotency between species. The intriguing possibility
that conventional hPSC cultures harbour a subset of cells with
identity to some earlier pluripotent cell type in pre-implantation
development likewise awaits further clarification. In this respect, it
is possible that a naïve epiblast state is simply much more difficult to
stabilise in primate versus mouse. The embryological identity of the
stable attractor state epitomised by human teratocarcinoma in vitro
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and in vivo, and by conventional hESCs and iPSCs, remains to be
defined, even after many years of study (Pera, 2014). Only through
further in-depth analysis of primate development will we be able to
ascertain which, if any, normal stage of human development the
various types of hPSCs equate to.
It could be argued that the search for human naïve cells is
predominantly an academic exercise and that many applications of
hESCs and iPSCs are, and will be, addressed using conventional
cell lines. However, if we are to use hPSCs as a high-fidelity model
for human development, if we wish to shed light on poorly
understood differences in differentiation potential and genetic and
epigenetic stability between PSC lines, if we wish to improve the
outcomes of hPSC differentiation and if we are to improve the
fidelity of cell reprogramming to pluripotency, then it becomes
important to understand how hPSCs fit into the paradigm of
embryonic development. The pursuit of naïve pluripotency in
human has already made important contributions towards this end.
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